GlobeNewswire

Elastic Unveils a Record Number of New Features and Previews Future Developments at Elastic{ON} 2018

Dela

With Over 225 Million Downloads, Elastic Opens-up X-Pack Codebase

 

SAN FRANCISCO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- (Elastic{ON} 2018) -  Elastic, the company behind Elasticsearch and the Elastic Stack, today announced that it has exceeded the 225 million product download milestone, up from 100 million one year ago. In addition, Elastic unveiled the opening of its X-Pack code as part of a strategy to make it easier for users to download, inspect, and collaborate with Elastic's engineering team on X-Pack feature development, which today includes features, such as, security, alerting, monitoring, Graph, and machine learning.

"We are truly humbled by the adoption of our products by millions of developers and thousands of customers who rely on them to power mission-critical use cases," said Shay Banon, Elastic Founder and CEO. "Opening up our X-Pack code will give users full transparency and the ability to collaborate with us, as they do with our open source products. This will help us create better products and features and enable us to build a sustainable business model that inspires innovation for every developer, every customer, and partner who uses our software."

Having acquired three new companies in past 18 months and with a user community that has grown to more than 100,000 developers around the world, Elastic{ON} 2018, is the single largest gathering of Elasticsearch users. Over three days, more than 2,500 attendees have come together to learn and share ideas, see the unveiling of a record number of new features, and get first-look previews of upcoming technology releases. 

  • Elastic APM: This first production-ready release of Elastic APM is an extension of Elastic's product stack into application performance. It allows application developers and devops engineers to monitor and analyze the impact of individual lines of code on system and business performance. This not only speeds, but also extends the debugging process, incorporating code performance into a holistic view of operational efficiency. Elastic APM stores data into an Elasticsearch index, allows for APM data to be correlated with logs and metrics collected via Logstash and Beats, includes a server-side component and agents for Node.js, Python, Ruby and JavaScript; and an APM app tailored for a typical APM workflow. Elastic APM is now available as part of the 6.2 release. 
     
  • Swiftype  App Search: Built for developers to add more powerful search functionality to their applications, Swiftype App Search delivers a robust set of APIs and additional search-specific features such as result positioning, synonyms, and typo-tolerance. Swiftype App Search is a turnkey SaaS solution requiring no infrastructure, management and maintenance, and offers an easy getting-started experience. Swiftype App Search is now available as a public beta. 
     
  • Machine Learning Forecasting : The first major extension of Elastic's machine learning capabilities extends functionality into the realm of predictive analytics. Users can model time series data and use sophisticated, ready-made, machine learning algorithms to forecast outcomes several time intervals into the future. With on-demand forecasting, users can take an existing machine learning job and, using the predictive model built into machine learning, gain accurate predictions on where that model is expected to grow over the forecast period. The forecast results are written to an Elasticsearch index allowing users to compare actual results to forecast models. Elastic's machine learning forecasting capabilities are now available as part of the 6.2 release.
     
  • GIS App: Elastic's newest {RE}search project, GIS (geographic information systems) is a system designed to capture, store, manipulate, analyze, manage, and present all types of geographical data. As part of Kibana, this app enables a new way to perform ad-hoc geospatial analysis; embed enhanced map visualizations into your dashboard; and includes key features, such as, support for multiple layers, mapping individual geo points and client side styling. The GIS app is currently in technology preview. 
     
  • SQL for Elasticsearch: This new feature opens up the power of the Elastic Stack to the world's most established database community of SQL developers, allowing users to query Elasticsearch data in familiar SQL Syntax. It also dramatically simplifies the (re)export of data from Elasticsearch back into external SQL environments with out-of-the-box JDBC support. By allowing Elasticsearch to understand SQL through a RESTful interface, SQL for Elasticsearch lets you query your Elasticsearch data using SQL syntax, returns results to those queries in a tabular form consistent with traditional SQL engines and provides a user interface to explore the data. SQL for Elasticsearch was introduced last year as a concept and will soon be available in an alpha and beta release. 
     
  • Canvas : Canvas provides an exciting new concept for the next generation of data visualization and data impressionism. With the incredible growth in the popularity of Kibana, Canvas represents a new way of exposing the insight gained from within the Elasticsearch data to live, real-time dashboards, presentations, and infographics. Canvas enables users to express the story of their Elasticsearch data like never before, eliminating the exhaustive, repetitive and time consuming process of exporting data into Excel to build a PowerPoint. Canvas is also pluggable, allowing users to bring in new data sources, visualization types, and UI components. Canvas was introduced last year as a concept and currently is in technology preview. 
     
  • Rollups: Commonly associated with metrics and logging use cases when storing data for long periods of time is required, rollups enable users to store a limited set of data, reducing the disk usage of historical data. An Elasticsearch rollup job allows users to configure periodic jobs that "rollup" or pre-aggregate data, and store the rollup in an index. One example is a metric like "average load time returned by the web server per hour," of which, the average data is rolled up and stored, but other raw data attributes like the specific user, page, and IP information are not. This will be available soon in a beta for Elasticsearch and later with Kibana support. 
     
  • Flexible Deployment Configurations: As customers put more and more data into Elasticsearch and expand their use cases, Elastic introduces the concept of "sliders" to give users the ability to customize their cluster configurations. Available for Elastic Cloud and Elastic Cloud Enterprise (ECE) customers, some of the new capabilities include: support for multiple classes of hardware; support for cluster templates and hot/warm clusters; and the ability to add machine learning, dedicated master nodes, and APM nodes to existing cluster configurations. These new features will be available soon in both Elastic Cloud and Elastic Cloud Enterprise. 
     
  • Logstash Azure Monitoring Module: Built in collaboration with Microsoft, the Logstash Azure Monitoring module is the easiest way to monitor your Azure infrastructure and services with the Elastic Stack. This new module integrates with Azure's centralized logging service to normalize Azure logs and metrics into JSON; uses Logstash to consume the data into Elasticsearch; and with Kibana, users can analyze infrastructure changes and authorization failures; identify suspicious activity and potential malicious actors; perform root-cause analysis by investigating user activity; and monitor and optimize SQL DB deployments. This will be available soon as a beta release.

Lastly, Elastic announced a new, official Elastic certification program. Fueled by user demand to have professional accreditation, Elastic will be offering new training curriculum designed for users to become experts and be certified by Elastic. New courses, Elasticsearch Engineer I and Elasticsearch Engineer II, will give users first-hand knowledge of installing, managing and optimizing Elasticsearch clusters, as well as, developing new solutions for analyzing their data. These courses are the foundation to becoming an Elastic Certified Engineer, which includes a hands-ons, technical and performance-based certification exam and an official digital Elastic certification badge for users who pass the exam.

Learn More

About Elastic
Elastic builds software to make data usable in real time and at scale for search, logging, security, and analytics use cases. Founded in 2012, the company develops the open source Elastic Stack (Elasticsearch, Kibana, Beats, and Logstash), X-Pack (commercial features), and Elastic Cloud (a hosted offering). To date, there have been more than 225 million cumulative downloads. Backed by Benchmark Capital, Index Ventures, and NEA with more than $100 million in funding, Elastic has a distributed workforce with more than 800 employees in 30 countries. Learn more at elastic.co.

Media Contacts
AMER
Michael Lindenberger
Reidy Communications for Elastic
Michael@reidycommunications.com 
(415) 531-1449

EMEA
Rory MacDonald
Age of Peers Ltd for Elastic
rory@ageofpeers.com
+44 (0)7899 965232




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Elastic via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum